The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase ιι (window) preoperative study of olaparib with cisplatin or with durvalumab or alone or no treatment in patients with histologically proven head and neck squamous cell carcinoma who are candidates for surgery (OPHELIA).
 
Amanda Psyrri
Honoraria - Merck Serono
Consulting or Advisory Role - AstraZeneca; Merck Serono; MSD Oncology; Pfizer
Other Relationship - Bristol-Myers Squibb; Janssen Oncology
 
George Papaxoinis
No Relationships to Disclose
 
Panagiota Economopoulou
No Relationships to Disclose
 
Ioannis Kotsantis
No Relationships to Disclose
 
Vassiliki Kotoula
No Relationships to Disclose
 
Onoufrios Tsavaris
No Relationships to Disclose
 
Chrysanthi Avgerinou
No Relationships to Disclose
 
George Fountzilas
No Relationships to Disclose